Navigation Links
Mast Therapeutics Reports First Quarter 2013 Financial Results
Date:5/15/2013

ther regulatory agencies may determine they are not sufficient to support a new drug application; the risk that even if clinical studies of MST-188 in one indication or jurisdiction are successful, clinical studies in another indication or jurisdiction may not be successful; the potential for unsuccessful nonclinical or clinical studies in one indication or jurisdiction, or by a future partner that may be outside of the Company's control, to adversely affect opportunities for MST-188 in other indications or jurisdictions; the Company's reliance on contract research organizations (CROs), contract manufacturing organizations (CMOs), and other third parties to assist in the conduct of important aspects of development of MST-188, including clinical studies, and regulatory activities for MST-188 and that such third parties may fail to perform as expected; the Company's ability to obtain additional funding on a timely basis or on acceptable terms, or at all; the potential for the Company to delay, reduce or discontinue current and/or planned development activities, including clinical studies, partner MST-188 at inopportune times or pursue less expensive but higher-risk and/or lower return development paths if it is unable to raise sufficient additional capital as needed; the risk that acceptable partnering opportunities for MST-188 may not be available in particular jurisdictions or indications and, consequently, the Company may not be able to pursue development of MST-188 in certain jurisdictions and indications; the risk that the FDA or any other regulatory agency does not grant marketing approval of MST-188, on a timely basis, or at all; the risk that the Company is not able to adequately protect its intellectual property rights relating to the MAST platform and MST‑188 and prevent competitors from duplicating or developing equivalent versions of its product candidates, including MST-188; and other risks and uncertainties more fully described in the Company's pre
'/>"/>
SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... YORK , Aug. 27, 2014 ... is available in its catalogue: Global ... http://www.reportlinker.com/p02316641/Global-Animal-Health-Market-2014-2018.html About Animal Health Animal ... animal diseases or treat animals to enhance their ... the yield of animal food. The Global Animal ...
(Date:8/27/2014)... Kewaunee Scientific Corporation (Nasdaq: KEQU ... quarterly cash dividend by 9% to twelve cents per ... with the dividend payable on September 22, 2014 to ... September 8, 2014. About Kewaunee Scientific ... Corporation is a recognized global leader in the design, ...
(Date:8/27/2014)... Conn. , Aug. 27, 2014  UBM Medica ... a leading online community for medical imaging professionals, presents ... Association for Medical Imaging Management,s 2014 Annual Meeting . ... conference coverage: , 11 Principles of ... can lead to greater profitability. , Why ...
Breaking Medicine Technology:Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3
... Generex Biotechnology Corporation (Nasdaq: GNBT ; ... diseases through the inner lining of the mouth, announced ... Licensing & Distribution Agreement with PMG S.A. ( www.pmgpharma.com ... Generex Oral-lyn™, the Company,s proprietary buccal insulin spray product, ...
... Corporation, a privately-held biotechnology company focused on developing a ... announced that Quinton Oswald has joined the company as ... significant commercial experience and management expertise to the CEO ... the Vice President & Business Unit Head for the ...
Cached Medicine Technology:Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile 2Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile 3Quinton Oswald Named Chief Executive Officer of SARcode Corporation 2Quinton Oswald Named Chief Executive Officer of SARcode Corporation 3
(Date:8/28/2014)... 28, 2014 Top 10 Best ... hosting companies and announces Bluehost, HostMonster ( http://www.hostmonster.com/track/seohosts ... for the webmasters worldwide who want to buy ... As the world’s most popular server-side scripting language, ... other general-purpose programs. It is now installed on ...
(Date:8/28/2014)... MMAR Medical is pleased to announce their Customer ... customers to enjoy several perks and benefits when shopping ... license. It’s a great choice for independent athletes, high ... regularly purchase medical braces but could use a discounted ... lifestyle or those of your club, group or team, ...
(Date:8/28/2014)... 2014 On September 1st, the National ... campaign. The goal is to help families and ... and effectively and without exposures to risky pesticides. ... “Children’s exposures to pesticides should be limited as ... Head lice are often trivialized in the media, which ...
(Date:8/27/2014)... A St. Louis law firm that represents ... that the C.R. Bard multidistrict litigation (MDL), an MDL ... lawsuits, recently filed a new pretrial order (PTO) on ... discovery process, and more specifically to the management of ... & Lowe is a law firm practicing defective medical ...
(Date:8/27/2014)... August 27, 2014 DentistSave.com ... plans, has launched in the state of Tennessee ... quality, affordable dental care services at reduced rates. ... Tennessee consumers looking to save money on their ... as a member of discount fee dental plan ...
Breaking Medicine News(10 mins):Health News:MMAR Medical Announces Customer Membership Program 2Health News:Head Lice Can Be a Public Health Opportunity 2Health News:Head Lice Can Be a Public Health Opportunity 3Health News:Head Lice Can Be a Public Health Opportunity 4Health News:Carey Danis & Lowe Reports On New Court Order in C.R. Bard Transvaginal Mesh MDL 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 3
... poor balance, dementia, vision loss most in peril, group says ... people are at high risk for accidental falls and should ... fall-related injuries and deaths in the United States, a new ... falls result in 1.8 million emergency room visits and more ...
... NEW YORK, Feb 4 March of Dimes New York ... as the,official Celebrity Chairman for March for Babies(SM) in New ... March of Dimes,premier fundraising event that benefits all babies-those born ... thrive., "I,m proud to be partnering with March of ...
... The Presidents proposed budget for fiscal year 2009, if ... by extension, our national effort to respond to the ... The Administrations budget flat-funds critical federal support for research ... programs at the Centers for Disease Control and Prevention ...
... FY 2009 Budget Blueprint ,Most Unreasonable, Most Unrealistic, ... Reacting to the formal,unveiling of the Bush ... Association (AHCA) said the proposal is unreasonable from ... in the face of worsening economic conditions in ...
... Clinic to Automate Three Offices with High Performance DR ... ... /PRNewswire-FirstCall/ - IDC (Imaging Dynamics Company,Ltd.) (TSX: IDL), the global leader ... a contract by,Orthopaedic Clinic of Daytona Beach in Florida for four ...
... Concludes (Again) That Antitrust Exemptions Increase Costs, ... (PCMA) issued the following statement in response to,the ... (S.B.,2190) that would allow individual and corporate health ... charge higher fees:, "This latest comment from ...
Cached Medicine News:Health News:New Guideline Urges Screening for Fall Risk 2Health News:Eli Manning Teams Up with March of Dimes in New York City 2Health News:2009 Bush budget a disaster for HIV/AIDS 2Health News:Bush Budget Represents 'Double Whammy' Hit on U.S. Seniors' Medicare-Financed Nursing Facility Care 2Health News:Orthopaedic Clinic of Daytona Beach Chooses IDC for Transition to Digital X-ray 2
The High Pure Viral RNA Kit is intended for general laboratory use and is designed to purify viral RNA from serum or plasma. Viral RNA is used for RT-PCR analysis directly after elution in nuclease-f...
... This revolutionary product will provide you ... type of electroretinogram, visual evoked potential, ... ganzfeld will allow you to perform ... on-off, double flash, photopic negative response, ...
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe...
... is designed for high throughput microplate processing. ... S60 Stacker that handles up to 60 ... base model is equipped with a dual ... units may be interfaced to increase flexibility ...
Medicine Products: